Anand Khristi is an accomplished Biopharmaceutical Formulation Scientist at Intas Accord Biopharmaceutical Pvt. Ltd., with deep expertise in the development and commercialization of complex protein-based therapeutics, including high concentration monoclonal antibodies, fusion proteins, and drug conjugates. Anand is adept at driving end-to-end formulation strategies, from conceptualization to large-scale production, with a specialization in lyophilization and advanced drug delivery systems.
In his current role, Anand leads a team of researchers, overseeing critical aspects of formulation design, process optimization, and compliance with Good Manufacturing Practices (GMP). His contributions have been instrumental in regulatory filings for Clinical Trial Applications (CTA), IND submissions, and tech transfers, with a focus on ensuring product quality and scalability. His work spans across cross-functional collaborations, ensuring seamless integration between R&D, analytical development, and manufacturing teams.
Anand holds three international patents related to innovative freeze-dried antibody formulations, novel formulation for monoclonal antibodies cocktail formulation and moisture determination methods for therapeutic proteins. He has also published four scientific papers in leading journals, with research topics ranging from the advanced characterization with Raman spectroscopy to novel drug delivery systems. His dedication to advancing biopharmaceutical science has been recognized through numerous awards for innovation and excellence in project execution.
Anand holds a Master of Science in Cell and Molecular Biology and continues to contribute to the field as a mentor, visiting faculty member, and advocate for scientific innovation.
